Check Point Care and the EIC Accelerator: A Virtual Ward at Home

Check Point Care, from Kazanlak in central Bulgaria, runs CheckPointCardio: a wearable that streams ECG and other vital signs to a round-the-clock "Virtual Ward", where AI and a medical team watch for patients whose condition is worsening. It was selected in the EIC Accelerator's January 2023 cut-off for blended finance and signed ARCHANGEL, a two-year project with a total cost of €3.48 million and an EU contribution of €2.44 million, running from August 2023 to July 2025, according to CORDIS. The aim was to take a service built for acutely ill patients and replicate it for people with chronic diseases at home.

The project is closed, and its final report states that the company "reached an optimized version of the Archangel system for chronic patients monitoring" and that the system "was fully deployed in collaboration with Hospitals and home care providers within our network", according to the CORDIS reporting page. The report claims the system allows a "90% decrease in patients deaths" compared with normal practice at host institutions, without citing a published study. The company's revenue and profit are not publicly available.

Where Check Point Care Stands Now

In September 2025 its chief business development officer, Kaja Vidic, told the EIC Scaling Club that the company operated in seven countries, was expanding to Denmark and Iceland, had "positive cash flow without external VC investment" and had doubled revenue every year for three years, while preparing a first venture round. In April 2025 it told SeeNews it was seeking €8.5 million in investment; five months later it was still preparing that first venture round.

The Technology: A Digital Twin of Each Patient

The wearable captures ECG and up to 100 vital parameters, which the platform turns into what the company calls 10,000 digital biomarkers, forming a digital twin of each patient. During ARCHANGEL the company built SpO2 sensors and a bracelet, added a core temperature sensor, designed a hub to forward data from all devices, and retrained its AI to detect deterioration in chronic patients, the final report states. The earlier system grew out of Nightingale, a Horizon 2020 pre-commercial procurement with university hospitals, after which revenues grew 40% a year, the European Commission reported.

What the EIC Award Promised, and What the Record Shows

The award promised to replicate the Virtual Ward model for chronic patients. The final report describes the hardware, AI and clinical protocols as built and piloted in two steps, first in the group's own medical centre and then with partner hospitals and home care providers. The report does not name those hospitals or give patient numbers for the chronic pilot, and no independent evaluation has been published.

1. Chronic-care systemDeliveredFinal report.
2. AI deterioration modelsDeliveredValidated on test data.
3. Pilot with partnersUnverifiedPartners not named.
4. 90% fewer deathsUnverifiedNo study cited.

The Money

Most of the EU money went to affiliated companies: €1.40 million to Check Point R&D and €593,250 to the group's medical centre, both registered as third parties, with €441,875 to Check Point Care itself, CORDIS data show. The EIC page for the project lists it under the EIC Fund, but the Bulgarian commercial register data published by finansi.bg show only individuals as shareholders, with Boycho Boychev, the chief executive named by the European Commission in 2023, and manager Boris Dimitrov holding 38.25% each. Whether the EIC's equity was ever invested is not public.

What Cannot Be Checked

Why Europe Should Care

The EIC's own project page says the system reduces hospital admissions, stays and visits. A company from a small Bulgarian town built a service that it says now runs in seven countries, with EU help at two stages. Its claims about lives saved deserve peer-reviewed evidence.

The Verdict

Check Point Care and the EIC have not been asked for comment for this article. It is based entirely on public records and published statements, linked throughout.